Viking Therapeutics (VKTX) Prepaid Assets (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Prepaid Assets came in at $1.2 million in Q1 2026, up 41.5% year-on-year from $865000.0 in Q1 2025, and down 32.23% quarter-over-quarter from $1.8 million in Q4 2025.
Viking Therapeutics (VKTX) Prepaid Assets (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Prepaid Assets across 13 years of filings, most recently posting $1.2 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $1.2 million, up 41.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 41.5% YoY), and the FY2025 annual result was $1.8 million, up 60.11% from the prior year.
- Prepaid Assets came in at $1.2 million for Q1 2026 at Viking Therapeutics, down from $1.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.9 million in Q1 2023 to a low of $138000.0 in Q2 2024.
- The 5-year median for Prepaid Assets is $1.1 million (2024), against an average of $1.6 million.
- Across the five-year window, Prepaid Assets slumped 85.62% in 2024 and soared 1939.86% in 2025, its largest moves.
- Viking Therapeutics' Prepaid Assets stood at $3.4 million in 2022, then retreated by 26.06% to $2.5 million in 2023, then tumbled by 55.27% to $1.1 million in 2024, then soared by 60.11% to $1.8 million in 2025, then plunged by 32.23% to $1.2 million in 2026.
- The last three Prepaid Assets figures came in at $1.2 million (Q1 2026), $1.8 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Viking Therapeutics | 3.50 Bn | 3.50 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.22 Mn |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 2.24 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Mar 31, 2025 | 865,000.00 |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 138,000.00 |
| Mar 31, 2024 | 643,000.00 |
| Dec 31, 2023 | 2.52 Mn |
| Sep 30, 2023 | 670,000.00 |
| Jun 30, 2023 | 960,000.00 |
| Mar 31, 2023 | 3.93 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Sep 30, 2022 | 956,000.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 388,000.00 |
| Dec 31, 2021 | 619,000.00 |
| Sep 30, 2021 | 915,000.00 |
| Jun 30, 2021 | 1.15 Mn |